Resolution on acquisition limit
Resolved 4 August 2025Market purchases under a discretionary trading agreement for the acquisition of treasury sharesThe full horizontal line represents all issued shares, with marks at 10% intervals. The colored section represents the percentage stated in the resolution as the maximum proportion that may be repurchased under it.
This is a limit, and does not mean that the company will buy back all of it. The amount actually acquired will be shown in a later disclosure on the status of the acquisition of treasury shares.
5 August 2025–29 May 2026
In connection with the resolution to express support for the tender offer for the Company's ordinary shares by MEDIPAL HOLDINGS CORPORATION and to recommend that the Company's shareholders tender their shares in the tender offer, the Company resolved to discontinue the acquisition of treasury shares.
| Item | Details |
|---|---|
| Class of shares to be acquired | Common shares |
| Maximum number of shares to be acquired | 1,500,000 shares (maximum) |
| Percentage of total issued shares | 2.43％ |
| Total acquisition price | ¥5 billion (maximum) |
| Acquisition period | 5 August 2025–29 May 2026 |
| Method of acquisition | Market purchases under a discretionary trading agreement for the acquisition of treasury shares |
| Reason for acquisition | In connection with the resolution to express support for the tender offer for the Company's ordinary shares by MEDIPAL HOLDINGS CORPORATION and to recommend that the Company's shareholders tender their shares in the tender offer, the Company resolved to discontinue the acquisition of treasury shares. |
| Resolution date | 4 August 2025 |
| Total number of issued shares | 1,500,000 shares (maximum); 2.43% of the total number of issued shares excluding treasury shares. Reference date: Not disclosed |
| Change in acquisition period | 5 August 2025–29 May 2026 → The acquisition was discontinued as of 11 May 2026 |
| Change in acquisition limit | 1,500,000 shares (maximum); ¥5 billion (maximum) → Discontinuation of acquisition |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company resolved to support the tender offer for its ordinary shares by its parent company, MEDIPAL HOLDINGS CORPORATION, and to recommend that its shareholders tender their shares.